Murchinson’s Inhibrx INBX Stock Holding History

Murchinson’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-33,790	Closed	-$482K	–	113
2025 Q2	$482K	Hold	33,790	–	–	0.17%	40
2025 Q1	$473K	Hold	33,790	–	–	0.03%	68
2024 Q4	$520K	Hold	33,790	–	–	0.22%	38
2024 Q3	$529K	Buy	33,790 +16,420	+95%	+$231K	0.14%	44
2024 Q2	$246K	Buy	+17,370	New	+$271K	0.04%	55

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Murchinson's INBX Position: Q3 2025 in Review

Murchinson sold out of Inhibrx (INBX) in Q3 2025, closing a stake of 33,790 shares — an estimated $482K sold.

Murchinson first reported a position in INBX in Q2 2024 and held it in 5 quarters. The position peaked at $529K in Q3 2024. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2025.

Murchinson reported no remaining Inhibrx position as of Q3 2025 after selling out during the quarter.
Murchinson sold 33,790 Inhibrx shares in Q3 2025, an estimated $482K.
Murchinson first reported a position in Inhibrx in Q2 2024 and held it in 5 quarters.
Murchinson's Inhibrx position peaked at $529K in Q3 2024.
102 funds tracked by Wall St. Rank held Inhibrx as of Q3 2025.

Based on Murchinson's 13F filing for Q3 2025, filed 14 Nov 2025.